Report Overview

The global digital PCR (dPCR) and real-time PCR (qPCR) market was pegged at US$ 4.48 billion in 2020 and is expected to witness a CAGR of~9.0% during the forecast period.

Market Fundamentals  

The polymerase chain reaction (PCR) is a basic molecular technique used for amplifying target sequences from a DNA template in an exponential manner. As significant amount of sample of DNA are necessary for molecular and genetic analysis,




PCR is a fast and inexpensive technique used to "amplify" and copy small segments of DNA. PCR is used in many areas of biology and medicine,




including molecular biology research,




medical diagnostics,




and even some branches of ecology.

[2123123]

Market Dynamics

The global digital PCR (dPCR) and real-time PCR (qPCR) market is mainly driven by rising prevalence of chronic diseases globally,




launch of technologically advanced systems &




kits,




and increasing use of biomarker profiling for disease diagnostics. Furthermore,




several initiatives by government bodies to fast-track the development of PCR is also likely to play a pivotal role in bolstering the market globally. However,




high cost,




false results and shortage of kits &




reagents owing to rising demand for COVID-19 testing are likely to restrain the market growth to a certain extent.

Market Ecosystem

The global digital PCR (dPCR) and real-time PCR (qPCR) market has been analyzed from five perspectives: Technology,




Offering,




Application,




End User,




and Region.

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Technology

[3420423]

Based on technology,




the market has been segmented into digital PCR (dPCR) and real-time PCR (qPCR). The real-time PCR (qPCR) segment accounted for the largest share in the market. The growth of the segment can be attributed mainly to its benefits such as fast start-up time,




better temperature control,




and real-time measurement. Demand for real-time PCR (qPCR) in fields such as genetic variation analysis,




gene expression analysis,




and genotyping is anticipated to propel the growth of the segment.

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Offering

Based on offering,




the digital PCR (dPCR) and real-time PCR (qPCR) market has been segmented into instruments,




reagents,




software and services. Reagents segment is expected to be the fastest growing segment in the market in the forecast period. The growth of the segment can be attributed to the easy accessibility of reagents,




their usage across wide range of applications and frequent purchase of reagents unlike instruments.

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Application

Based on application,




the digital PCR (dPCR) and real-time PCR (qPCR) market has been segmented into clinical application,




research application and forensic application. Clinical application segment dominated the market with the largest share. The growth of the segment can be attributed to rising prevalence of chronic &




acute diseases,




growing adoption of dPCR in hospitals &




diagnostic centers and growing public awareness regarding early &




effective disease diagnosis &




treatment.

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by End User

Based on end user,




the digital PCR (dPCR) and real-time PCR (qPCR) market has been segmented into hospitals,




academic institutes &




research centers,




diagnostic centers and others (clinics, pharmaceutical & biotechnology companies, etc.). Diagnostic centers segment dominated the market owing to the increasing number of diagnostic centers coupled with growing adoption of the dPCR in diagnostic centers and the rise in testing for detection of COVID-19 on an enormous scale.

Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Region

Based on region,




the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market has been segmented into North America,




Europe,




Asia Pacific,




and the Rest of the World (ROW). North America dominated the Digital PCR (dPCR) and Real-Time PCR (qPCR) market,




followed by Asia Pacific. The large share of North America in the global market can largely be attributed to developed healthcare infrastructure,




launch of technologically advanced products,




and presence of large number of clinical laboratories in the region. Moreover,




presence of large number of prominent players and their rising collaboration for launch of advance PCR technology &




reagents are also expected to boost the market.

Competitive Landscape

Some of the prominent players operating in the digital PCR (dPCR) and real-time PCR (qPCR) market includes:-

• Merck KGaA
• Thermo Fisher Scientific
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• BD
• Agilent Technologies,
  
  
  
  
  Inc
• bioMérieux SA
• Danaher
• Bio-Rad Laboratories, Inc
• QIAGEN, among others

Strategic Developments

• In Dec 2020, Roche announced launch of high-throughput SARS-CoV-2 antigen test in the European market. The antigen test is designed as an aid in the diagnosis of SARS-CoV-2, the virus causing COVID-19, in markets accepting the CE Mark
• In Dec 2020, SpiceHealth has signed Memorandum of Understanding (MoU) with CSIR - Centre for Cellular and Molecular Biology (CCMB), a constituent lab of Council of Scientific and Industrial Research, for conducting dry swab direct Real-Time Polymerase Chain Reaction (RT-PCR) tests in its mobile testing laboratories
• In Sept 2020, QIAGEN N.V. announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN's portfolio of automated molecular testing solutions based on the proven PCR technology

Frequently Asked Questions About This Report